» Articles » PMID: 25356352

Multi-drug Resistance and Reduced Susceptibility to Ciprofloxacin Among Salmonella Enterica Serovar Typhi Isolates from the Middle East and Central Asia

Overview
Publisher Elsevier
Date 2014 Oct 31
PMID 25356352
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Typhoid fever is common in developing countries, with an estimated 120 million infections and 700 000 annual deaths, worldwide. Fluoroquinolones have been the treatment of choice for infection with multidrug-resistant (MDR) Salmonella enterica serovar Typhi (S. Typhi). However, alarming reports of fluoroquinolone-resistance and failure of typhoid fever treatment have recently been published. To determine the proportion of S. Typhi isolates with reduced susceptibility to ciprofloxacin (RSC) from six countries in the Middle East and Central Asia, 968 S. Typhi isolates collected between 2002 and 2007 from Egypt, Uzbekistan, Pakistan, Qatar, Jordan and Iraq were tested for antibiotic susceptibility to five antibiotics using the disc-diffusion method. MDR was defined as resistance to amicillin, chloramphenicol and trimethoprim-sulfamethoxazole. The E-test was employed to determine the MIC of ciprofloxacin only. Nalidixic acid resistance was evaluated as a marker for RSC. Interpretations were made according to CLSI guidelines. MDR strains were considerably more prevalent in Iraq (83%) and Pakistan (52%) compared with the other countries studied (13-52%). Nearly all isolates were susceptible (99.7%) to ceftriaxone. RSC was detected in a total of 218 isolates (22%), mostly from Iraq (54/59, 92%), Uzbekistan (98/123, 80%), Qatar (23/43, 54%) and Pakistan (31/65, 47%). Many of these (21%) were also MDR. Use of nalidixic acid resistance as an indicator for RSC was 99% sensitive and 98% specific. This study reinforces the need for routine antimicrobial susceptibility surveillance of enteric fever isolates and close review of current therapeutic policies in the region.

Citing Articles

Antibiotic resistance in the Middle East and Southern Asia: a systematic review and meta-analysis.

Mathu R, Diago-Navarro E, Lynch E, Degail M, Ousley J, Kanapathipillai R JAC Antimicrob Resist. 2025; 7(1):dlaf010.

PMID: 39973906 PMC: 11836886. DOI: 10.1093/jacamr/dlaf010.


Typhoidal salmonella disease in Mukuru informal settlement, Nairobi Kenya; carriage, diversity, and antimicrobial resistant genes.

Kasiano P, Kavai S, Kiiru S, Nyerere A, Kariuki S PLoS One. 2024; 19(2):e0298635.

PMID: 38394140 PMC: 10889635. DOI: 10.1371/journal.pone.0298635.


A pattern of antibiotic drug resistance of Salmonella Typhi and Salmonella Paratyphi among children with enteric fever in a tertiary care hospital in Lahore, Pakistan.

Baig U, Mehdi S, Iftikhar N Croat Med J. 2023; 64(4):256-264.

PMID: 37654037 PMC: 10509684.


Hotspots sequences of gyrA, gyrB, parC, and parE genes encoded for fluoroquinolones resistance from local Salmonella Typhi strains in Jakarta.

Nathania I, Nainggolan I, Yasmon A, Nusatia A, Tjoa E, Gunardi W BMC Microbiol. 2022; 22(1):250.

PMID: 36253712 PMC: 9578181. DOI: 10.1186/s12866-022-02666-z.


Detection of multidrug-resistant subsp. serovar Typhi isolated from Iraqi subjects.

Salman H, Abdulmohsen A, Falih M, Romi Z Vet World. 2021; 14(7):1922-1928.

PMID: 34475718 PMC: 8404135. DOI: 10.14202/vetworld.2021.1922-1928.


References
1.
Al-Sanouri T, Paglietti B, Haddadin A, Murgia M, Bacciu D, Youssef M . Emergence of plasmid-mediated multidrug resistance in epidemic and non-epidemic strains of Salmonella enterica serotype Typhi from Jordan. J Infect Dev Ctries. 2009; 2(4):295-301. DOI: 10.3855/jidc.225. View

2.
Wasfy M, Frenck R, Ismail T, Mansour H, Malone J, Mahoney F . Trends of multiple-drug resistance among Salmonella serotype Typhi isolates during a 14-year period in Egypt. Clin Infect Dis. 2002; 35(10):1265-8. DOI: 10.1086/343052. View

3.
Parry C, Hien T, Dougan G, White N, Farrar J . Typhoid fever. N Engl J Med. 2002; 347(22):1770-82. DOI: 10.1056/NEJMra020201. View

4.
Kownhar H, Shankar E, Rajan R, Rao U . Emergence of nalidixic acid-resistant Salmonella enterica serovar Typhi resistant to ciprofloxacin in India. J Med Microbiol. 2006; 56(Pt 1):136-137. DOI: 10.1099/jmm.0.46763-0. View

5.
Korzeniewski K . The epidemiological situation in Iraq. Przegl Epidemiol. 2007; 60(4):845-55. View